Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate trial for persistent symptoms of hypothyroidism
ISRCTN68248063Phase 2Recruiting
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Hashimoto's disease and hypothyroidism comparing Mycophenolate mofetil with Placebo (2 arms). Primary endpoint: Change in numbers of CD45+ thyroid lymphocytes. Started Mar 2025; status: recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
Hashimoto's diseasehypothyroidism
Beyond the preview
Go deeper on ISRCTN68248063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN68248063.